v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenues:    
Total revenues $ 15,248 $ 7,543
Costs and operating expenses:    
Cost of product revenue 2,064 2,732
Research and development 11,448 12,942
Selling, general and administrative 9,779 12,355
Total costs and operating expenses 23,291 28,029
Loss from operations (8,043) (20,486)
Interest income 665 751
Interest and other expense, net (1,290) (942)
Loss before income taxes (8,668) (20,677)
Provision for income taxes (36) (11)
Net loss $ (8,704) $ (20,688)
Net loss per share, basic (in dollars per share) $ (0.10) $ (0.25)
Net loss per share, diluted (in dollars per share) $ (0.10) $ (0.25)
Weighted average common stock shares used in computing net loss per share, basic (in shares) 90,768 82,410
Weighted average common stock shares used in computing net loss per share, diluted (in shares) 90,768 82,410
Product revenue    
Revenues:    
Total revenues $ 7,191 $ 6,059
Research and development revenue    
Revenues:    
Total revenues $ 8,057 $ 1,484

Source